SZSE:300725 (China)
Â
Class A
Â¥
34.90
(-0.88%)
Dec 27
Business Description
Pharma Block Sciences (Nanjing) Inc
ISIN : CNE1000035K5
Share Class Description:
SZSE:300725: Class ACompare
Compare
Traded in other countries / regions
300725.China IPO Date
2017-11-10Description
Pharma Block Sciences (Nanjing) Inc is a chemistry products and services provider through the pharmaceutical research and development process. Its core business activities include pilot plant and commercial manufacturing of key intermediates and active pharmaceutical ingredient, process development, custom synthesis and building blocks.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.4 | |||||
| Equity-to-Asset | 0.59 | |||||
| Debt-to-Equity | 0.52 | |||||
| Debt-to-EBITDA | 5.69 | |||||
| Interest Coverage | 3.78 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 3.46 | |||||
| Beneish M-Score | -2.58 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 16.4 | |||||
| 3-Year EBITDA Growth Rate | 17.9 | |||||
| 3-Year EPS without NRI Growth Rate | -1.6 | |||||
| 3-Year Book Growth Rate | 12.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 20.71 | |||||
| Future 3-5Y Total Revenue Growth Rate | 12.81 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 31.6 | |||||
| 9-Day RSI | 38.63 | |||||
| 14-Day RSI | 43.33 | |||||
| 6-1 Month Momentum % | 30.04 | |||||
| 12-1 Month Momentum % | -6.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.33 | |||||
| Quick Ratio | 2.21 | |||||
| Cash Ratio | 0.74 | |||||
| Days Inventory | 310.24 | |||||
| Days Sales Outstanding | 101.77 | |||||
| Days Payable | 112.75 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.89 | |||||
| Dividend Payout Ratio | 0.36 | |||||
| 3-Year Dividend Growth Rate | -4.6 | |||||
| Forward Dividend Yield % | 0.89 | |||||
| 5-Year Yield-on-Cost % | 0.62 | |||||
| 3-Year Average Share Buyback Ratio | -1.9 | |||||
| Shareholder Yield % | 3.64 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 40.2 | |||||
| Operating Margin % | 15.33 | |||||
| Net Margin % | 11.21 | |||||
| FCF Margin % | 12.32 | |||||
| ROE % | 6.13 | |||||
| ROA % | 3.51 | |||||
| ROIC % | 5.4 | |||||
| ROC (Joel Greenblatt) % | 7.94 | |||||
| ROCE % | 6.38 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 40.35 | |||||
| Forward PE Ratio | 27.92 | |||||
| PE Ratio without NRI | 40.68 | |||||
| Shiller PE Ratio | 36.35 | |||||
| PEG Ratio | 1.82 | |||||
| PS Ratio | 4.47 | |||||
| PB Ratio | 2.4 | |||||
| Price-to-Tangible-Book | 2.86 | |||||
| Price-to-Free-Cash-Flow | 36.27 | |||||
| Price-to-Operating-Cash-Flow | 24.24 | |||||
| EV-to-EBIT | 30.19 | |||||
| EV-to-EBITDA | 30.19 | |||||
| EV-to-Revenue | 5.08 | |||||
| EV-to-FCF | 41.42 | |||||
| Price-to-Projected-FCF | 4.51 | |||||
| Price-to-Peter-Lynch-Fair-Value | 5.24 | |||||
| Price-to-Graham-Number | 2.27 | |||||
| Price-to-Net-Current-Asset-Value | 10.36 | |||||
| Earnings Yield (Greenblatt) % | 3.31 | |||||
| FCF Yield % | 2.76 | |||||
| Forward Rate of Return (Yacktman) % | 6.86 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pharma Block Sciences (Nanjing) Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,561.634 | ||
| EPS (TTM) (Â¥) | 0.865 | ||
| Beta | 1.89 | ||
| Volatility % | 67.3 | ||
| 14-Day RSI | 43.33 | ||
| 14-Day ATR (Â¥) | 1.237441 | ||
| 20-Day SMA (Â¥) | 36.269 | ||
| 12-1 Month Momentum % | -6.33 | ||
| 52-Week Range (Â¥) | 23.25 - 45.36 | ||
| Shares Outstanding (Mil) | 199.73 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pharma Block Sciences (Nanjing) Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pharma Block Sciences (Nanjing) Inc Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pharma Block Sciences (Nanjing) Inc Frequently Asked Questions
What is Pharma Block Sciences (Nanjing) Inc(SZSE:300725)'s stock price today?
The current price of SZSE:300725 is ¥34.90. The 52 week high of SZSE:300725 is ¥45.36 and 52 week low is ¥23.25.
When is next earnings date of Pharma Block Sciences (Nanjing) Inc(SZSE:300725)?
The next earnings date of Pharma Block Sciences (Nanjing) Inc(SZSE:300725) is 2025-04-24 Est..
Does Pharma Block Sciences (Nanjing) Inc(SZSE:300725) pay dividends? If so, how much?
The Dividend Yield %  of Pharma Block Sciences (Nanjing) Inc(SZSE:300725) is 0.89% (As of Today), Highest Dividend Payout Ratio of Pharma Block Sciences (Nanjing) Inc(SZSE:300725) was 0.36. The lowest was 0.07. And the median was 0.12. The  Forward Dividend Yield % of Pharma Block Sciences (Nanjing) Inc(SZSE:300725) is 0.89%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers